Baxter (BAX) Smacked on Solid Results from Biogen's (BIIB) Hemophilia Drug
Go back to Baxter (BAX) Smacked on Solid Results from Biogen's (BIIB) Hemophilia Drug| Baxter International Inc. (NYSE: BAX) | Delayed: 26.22 -0.51 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.73 | 52 Week High | $50.16 | |||
| Open | $26.47 | 52 Week Low | $34.06 | |||
| Day High | $26.47 | P/E | 7.16 | |||
| Day Low | $26.14 | EPS | $3.66 | |||
| Volume | 1,182,399 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.78 -0.05 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.83 | 52 Week High | $333.65 | |||
| Open | $208.36 | 52 Week Low | $223.02 | |||
| Day High | $210.32 | P/E | 26.86 | |||
| Day Low | $207.62 | EPS | $7.81 | |||
| Volume | 118,160 | |||||
